COPD exacerbations: definitions and classifications

被引:332
作者
Burge, S
Wedzicha, JA
机构
[1] Birmingham Heartlands Hosp, Birmingham B9 5SS, W Midlands, England
[2] St Bartholomews & Royal London Sch Med, Acad Unit Resp Med, London, England
关键词
chronic obstructive pulmonary; disease actiology; definition; exacerbation; incidence; prevention;
D O I
10.1183/09031936.03.00078002
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Chronic obstructive pulmonary disease (COPD) is defined independently of exacerbations, which are largely a feature of moderate-to-severe disease. This article is the result of a workshop that tried to define exacerbations of COPD for Use in clinical, pharmacological and epidemiological studies. The conclusions represent the consensus of those present. This review describes definitions, ascertainment, severity assessments, duration and frequency, using varying sources of data including direct patient interview, healthcare databases and symptom diaries kept by patients in studies. The best general definition of a COPD exacerbation is the following: an exacerbation of COPD is a sustained worsening of the patient's condition, from the stable state and beyond normal day-to-day variations that is acute in onset and may warrant additional treatment in a patient with underlying COPD. A more specific definition for studies where a bacteriological cause of exacerbation is being studied is included, as well as simpler definitions for retrospective identification from database sources. Prospective diary card assessments are best recorded as changes from an agreed baseline, rather than absolute symptom severities. Diary cards identify many unreported exacerbations, which on average have similar severities to reported exacerbations. A scale for exacerbation severity is proposed that incorporates in- and outpatient assessments. Exacerbation duration, which also relates to severity, is defined from diary card reports. Healthcare utilisation is not an adequate substitute for severity, depending on many unrelated social and comorbidity factors. It is an outcome in its own right.
引用
收藏
页码:46S / 53S
页数:8
相关论文
共 48 条
  • [1] Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD
    Adams, SG
    Melo, J
    Luther, M
    Anzueto, A
    [J]. CHEST, 2000, 117 (05) : 1345 - 1352
  • [2] ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    ANTHONISEN, NR
    MANFREDA, J
    WARREN, CPW
    HERSHFIELD, ES
    HARDING, GKM
    NELSON, NA
    [J]. ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) : 196 - 204
  • [3] BALL P, 1995, QJM-INT J MED, V88, P61
  • [4] Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations
    Bhowmik, A
    Seemungal, TAR
    Sapsford, RJ
    Wedzicha, JA
    [J]. THORAX, 2000, 55 (02) : 114 - 120
  • [5] *BRIT THOR SOC, 1997, THORAX S1, V52, pS1, DOI DOI 10.1136/THX.52.2008.S1]
  • [6] Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
    Burge, PS
    Calverley, PMA
    Jones, PW
    Spencer, S
    Anderson, JA
    Maslen, TK
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7245): : 1297 - 1303
  • [7] Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
    Calverley, P
    Pauwels, R
    Vestbo, J
    Jones, P
    Pride, N
    Gulsvik, A
    Anderson, J
    Maden, C
    [J]. LANCET, 2003, 361 (9356) : 449 - 456
  • [8] CALVERLEY PM, 2003, IN PRESS CHEST
  • [9] A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
    Casaburi, R
    Mahler, DA
    Jones, PW
    Wanner, A
    San Pedro, G
    ZuWallack, RL
    Menjoge, SS
    Serby, CW
    Witek, T
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (02) : 217 - 224
  • [10] Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older:: a prospective study
    Christenson, B
    Lundbergh, P
    Hedlund, J
    Örtqvist, Å
    [J]. LANCET, 2001, 357 (9261) : 1008 - 1011